{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T03:39:33Z","timestamp":1795059573099,"version":"4.10.2"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T00:00:00Z","timestamp":1749254400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T00:00:00Z","timestamp":1749254400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012659","name":"Foundation for Innovative Research Groups of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No.82270804, NO.82470792"],"award-info":[{"award-number":["No.82270804, NO.82470792"]}],"id":[{"id":"10.13039\/501100012659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-025-03511-x","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T21:13:14Z","timestamp":1749244394000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Genetically engineered T cell membrane-camouflaged nanoparticles triggered cuproptosis for synergistic bladder cancer photothermal-immunotherapy"],"prefix":"10.1186","volume":"23","author":[{"given":"Wen","family":"Deng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongke","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haojie","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zichen","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaozhuo","family":"Ba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghua","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kehua","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,7]]},"reference":[{"key":"3511_CR1","doi-asserted-by":"publisher","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023, (in eng). CA Cancer J Clin. 2023;73(1):17\u201348. https:\/\/doi.org\/10.3322\/caac.21763","DOI":"10.3322\/caac.21763"},{"key":"3511_CR2","doi-asserted-by":"publisher","unstructured":"Pettenati C, Ingersoll MA. Mechanisms of BCG immunotherapy and its outlook for bladder cancer, (in eng). Nat Rev Urol. 2018;15(10):615\u2013625. https:\/\/doi.org\/10.1038\/s41585-018-0055-4","DOI":"10.1038\/s41585-018-0055-4"},{"key":"3511_CR3","doi-asserted-by":"publisher","unstructured":"Wu Z et al. Adverse Events of Immune Checkpoint Inhibitors Therapy for Urologic Cancer Patients in Clinical Trials: A Collaborative Systematic Review and Meta-analysis, (in eng). Eur Urol. 2022;81(4):414\u2013425. https:\/\/doi.org\/10.1016\/j.eururo.2022.01.028","DOI":"10.1016\/j.eururo.2022.01.028"},{"key":"3511_CR4","doi-asserted-by":"publisher","unstructured":"Meier P, Legrand AJ, Adam D, Silke J. Immunogenic cell death in cancer: targeting necroptosis to induce antitumour immunity, (in eng). Nat Rev Cancer. 2024;24(5):299\u2013315. https:\/\/doi.org\/10.1038\/s41568-024-00674-x","DOI":"10.1038\/s41568-024-00674-x"},{"key":"3511_CR5","doi-asserted-by":"publisher","unstructured":"Aaes TL, Vandenabeele P. The intrinsic immunogenic properties of cancer cell lines, immunogenic cell death, and how these influence host antitumor immune responses, (in eng). Cell Death Differ. 2021;28(3):843\u2013860. https:\/\/doi.org\/10.1038\/s41418-020-00658-y","DOI":"10.1038\/s41418-020-00658-y"},{"key":"3511_CR6","doi-asserted-by":"publisher","unstructured":"Krysko DV, Garg AD, Kaczmarek A, Krysko O, Agostinis P, Vandenabeele P. Immunogenic cell death and damps in cancer therapy. Nat Rev Cancer. 2012;12(12):860\u201375. https:\/\/doi.org\/10.1038\/nrc3380","DOI":"10.1038\/nrc3380"},{"key":"3511_CR7","doi-asserted-by":"publisher","unstructured":"Kroemer G, Galassi C, Zitvogel L, Galluzzi L. Immunogenic cell stress and death, (in eng). Nat Immunol. 2022;23(4):487\u2013500. https:\/\/doi.org\/10.1038\/s41590-022-01132-2","DOI":"10.1038\/s41590-022-01132-2"},{"key":"3511_CR8","doi-asserted-by":"publisher","unstructured":"Niu X, Chen L, Li Y, Hu Z, He F. Ferroptosis, necroptosis, and pyroptosis in the tumor microenvironment: perspectives for immunotherapy of SCLC, (in eng). Semin Cancer Biol. 2022;86:273\u201385. https:\/\/doi.org\/10.1016\/j.semcancer.2022.03.009","DOI":"10.1016\/j.semcancer.2022.03.009"},{"key":"3511_CR9","doi-asserted-by":"publisher","unstructured":"Overchuk M, Weersink RA, Wilson BC, Zheng G. Photodynamic and Photothermal Therapies: Synergy Opportunities for Nanomedicine, (in eng). ACS Nano. 2023;17(9):7979\u20138003. https:\/\/doi.org\/10.1021\/acsnano.3c00891","DOI":"10.1021\/acsnano.3c00891"},{"key":"3511_CR10","doi-asserted-by":"publisher","unstructured":"Wang Y et al. A Self-Evaluating Photothermal Therapeutic Nanoparticle, (in eng). ACS Nano. 2020;14(8):9585\u20139593. https:\/\/doi.org\/10.1021\/acsnano.9b10144","DOI":"10.1021\/acsnano.9b10144"},{"key":"3511_CR11","doi-asserted-by":"publisher","unstructured":"Bian J et al. Engineering AIEgens-Tethered Gold Nanoparticles with Enzymatic Dual Self-Assembly for Amplified Cancer-Specific Phototheranostics, (in eng). ACS Nano. 2024;18(39):26784\u201326798. https:\/\/doi.org\/10.1021\/acsnano.4c07403","DOI":"10.1021\/acsnano.4c07403"},{"key":"3511_CR12","doi-asserted-by":"publisher","unstructured":"Deng W, et al. The application of nanoparticles-based ferroptosis, pyroptosis and autophagy in cancer immunotherapy. J Nanobiotechnol. 2024;22(1):97. (in eng). https:\/\/doi.org\/10.1186\/s12951-024-02297-8","DOI":"10.1186\/s12951-024-02297-8"},{"key":"3511_CR13","doi-asserted-by":"publisher","unstructured":"Shang T, Yu X, Han S, Yang B. Nanomedicine-based tumor photothermal therapy synergized immunotherapy, (in eng). Biomater Sci. 2020;8(19):5241\u201359. https:\/\/doi.org\/10.1039\/d0bm01158d","DOI":"10.1039\/d0bm01158d"},{"key":"3511_CR14","doi-asserted-by":"publisher","unstructured":"Fan Q et al. Multiple Synergistic Effects of the Microglia Membrane-Bionic Nanoplatform on Mediate Tumor Microenvironment Remodeling to Amplify Glioblastoma Immunotherapy, (in eng). ACS Nano. 2024;18(22);14469\u201314486. https:\/\/doi.org\/10.1021\/acsnano.4c01253","DOI":"10.1021\/acsnano.4c01253"},{"key":"3511_CR15","doi-asserted-by":"publisher","unstructured":"Ma G et al. Polydopamine Nanostructure-Enhanced Water Interaction with pH-Responsive Manganese Sulfide Nanoclusters for Tumor Magnetic Resonance Contrast Enhancement and Synergistic Ferroptosis-Photothermal Therapy, (in eng). ACS Nano. 2024;18(4):3369\u20133381. https:\/\/doi.org\/10.1021\/acsnano.3c10249","DOI":"10.1021\/acsnano.3c10249"},{"key":"3511_CR16","doi-asserted-by":"publisher","unstructured":"Xie J, Yang Y, Gao Y, He J. Cuproptosis: mechanisms and links with cancers. Mol Cancer (in eng). 2023;22(1):46. https:\/\/doi.org\/10.1186\/s12943-023-01732-y","DOI":"10.1186\/s12943-023-01732-y"},{"key":"3511_CR17","doi-asserted-by":"publisher","unstructured":"Wu L et al. Bioorthogonal Cu Single-Atom Nanozyme for Synergistic Nanocatalytic Therapy, Photothermal Therapy, Cuproptosis and Immunotherapy, (in eng). Angew Chem Int Ed Engl. 2024;63(27):e202405937. https:\/\/doi.org\/10.1002\/anie.202405937","DOI":"10.1002\/anie.202405937"},{"key":"3511_CR18","doi-asserted-by":"publisher","unstructured":"Fang RH, Gao W, Zhang L. Targeting drugs to tumours using cell membrane-coated nanoparticles. Nat Rev Clin Oncol (in eng). 2023;20(1):33\u201348. https:\/\/doi.org\/10.1038\/s41571-022-00699-x","DOI":"10.1038\/s41571-022-00699-x"},{"key":"3511_CR19","doi-asserted-by":"publisher","unstructured":"Zhong Z et al. Cell membrane coated nanoparticles as a biomimetic drug delivery platform for enhancing cancer immunotherapy, (in eng). Nanoscale. 2024;16(18);8708\u20138738. https:\/\/doi.org\/10.1039\/d4nr00284a","DOI":"10.1039\/d4nr00284a"},{"key":"3511_CR20","doi-asserted-by":"publisher","unstructured":"Luk BT, Zhang L, Cell membrane-camouflaged nanoparticles for drug delivery, (in eng). J Control Release. 2015;220:600-7. https:\/\/doi.org\/10.1016\/j.jconrel.2015.07.019","DOI":"10.1016\/j.jconrel.2015.07.019"},{"key":"3511_CR21","doi-asserted-by":"publisher","first-page":"3333","DOI":"10.2147\/ijn.S447350","volume":"19","author":"Q Huang","year":"2024","unstructured":"Huang Q, et al. The application of nanoparticles targeting Cancer-Associated fibroblasts, (in eng). Int J Nanomed. 2024;19:3333\u201365. https:\/\/doi.org\/10.2147\/ijn.S447350.","journal-title":"Int J Nanomed"},{"key":"3511_CR22","doi-asserted-by":"publisher","unstructured":"Cichocki F et al. Quadruple gene-engineered natural killer cells enable multi-antigen targeting for durable antitumor activity against multiple myeloma, (in eng). Nat Commun. 2022;13(1):7341. https:\/\/doi.org\/10.1038\/s41467-022-35127-2","DOI":"10.1038\/s41467-022-35127-2"},{"key":"3511_CR23","doi-asserted-by":"publisher","unstructured":"Liu L, Pan Y, Zhao C, Huang P, Chen X, Rao L. Boosting Checkpoint Immunotherapy with Biomaterials, (in eng). ACS Nano. 2023;17(4):3225\u20133258. https:\/\/doi.org\/10.1021\/acsnano.2c11691","DOI":"10.1021\/acsnano.2c11691"},{"key":"3511_CR24","doi-asserted-by":"publisher","unstructured":"Sun X, Tian T, Lian Y, Cui Z. Current Advances in Viral Nanoparticles for Biomedicine, (in eng). ACS Nano. 2024;18(50):33827\u201333863. https:\/\/doi.org\/10.1021\/acsnano.4c13146","DOI":"10.1021\/acsnano.4c13146"},{"issue":"4","key":"3511_CR25","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1021\/nl500618u","volume":"14","author":"RH Fang","year":"2014","unstructured":"Fang RH, et al. Cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery. Nano Lett (in eng). 2014;14(4):2181\u20138. https:\/\/doi.org\/10.1021\/nl500618u","journal-title":"Nano Lett"},{"key":"3511_CR26","doi-asserted-by":"publisher","unstructured":"Mei J et al. Biofilm Microenvironment-Responsive Self-Assembly Nanoreactors for All-Stage Biofilm Associated Infection through Bacterial Cuproptosis-like Death and Macrophage Re-Rousing, (in eng). Adv Mater. 2023;35(36):e2303432. https:\/\/doi.org\/10.1002\/adma.202303432","DOI":"10.1002\/adma.202303432"},{"key":"3511_CR27","doi-asserted-by":"publisher","unstructured":"Tang D, Kroemer G, Kang R. Targeting Cuproplasia and Cuproptosis in cancer, (in eng). Nat Rev Clin Oncol. 2024;21(5):370\u201388. https:\/\/doi.org\/10.1038\/s41571-024-00876-0","DOI":"10.1038\/s41571-024-00876-0"},{"key":"3511_CR28","doi-asserted-by":"publisher","unstructured":"Kahlson MA, Dixon SJ. Copper-induced cell death, (in eng). Science. 2022;375(6586):1231\u20131232. https:\/\/doi.org\/10.1126\/science.abo3959","DOI":"10.1126\/science.abo3959"},{"key":"3511_CR29","doi-asserted-by":"publisher","unstructured":"Wang D et al. Jul., The molecular mechanisms of cuproptosis and its relevance to cardiovascular disease, (in eng). Biomed Pharmacother. 2023;163:114830. https:\/\/doi.org\/10.1016\/j.biopha.2023.114830","DOI":"10.1016\/j.biopha.2023.114830"},{"key":"3511_CR30","doi-asserted-by":"publisher","unstructured":"Chen L, Min J, Wang F. Copper homeostasis and cuproptosis in health and disease, (in eng). Signal Transduct Target Ther. 2022;7(1):378. https:\/\/doi.org\/10.1038\/s41392-022-01229-y","DOI":"10.1038\/s41392-022-01229-y"},{"key":"3511_CR31","doi-asserted-by":"publisher","unstructured":"Yi M, Zheng X, Niu M, Zhu S, Ge H, Wu K. Jan 21, Combination strategies with PD-1\/PD-L1 blockade: current advances and future directions, (in eng). mol Cancer. 2022;21(1):28. https:\/\/doi.org\/10.1186\/s12943-021-01489-2","DOI":"10.1186\/s12943-021-01489-2"},{"key":"3511_CR32","doi-asserted-by":"publisher","first-page":"1016646","DOI":"10.3389\/fimmu.2022.1016646","volume":"13","author":"J Shan","year":"2022","unstructured":"Shan J, Han D, Shen C, Lei Q, Zhang Y. Mechanism and strategies of immunotherapy resistance in colorectal cancer. Front Immunol (in eng). 2022;13:1016646. https:\/\/doi.org\/10.3389\/fimmu.2022.1016646","journal-title":"Front Immunol"},{"key":"3511_CR33","doi-asserted-by":"publisher","unstructured":"Marei HE, Hasan A, Pozzoli G, Cenciarelli C. Cancer immunotherapy with immune checkpoint inhibitors (ICIs): potential, mechanisms of resistance, and strategies for reinvigorating T cell responsiveness when resistance is acquired. Cancer Cell Int (in eng). 2023;23(1):64. https:\/\/doi.org\/10.1186\/s12935-023-02902-0","DOI":"10.1186\/s12935-023-02902-0"},{"key":"3511_CR34","doi-asserted-by":"publisher","unstructured":"Jiao J et al. Redox and pH dual-responsive PEG and chitosan-conjugated hollow mesoporous silica for controlled drug release, (in eng). Mater Sci Eng C Mater Biol Appl. 2016;67:26\u201333. https:\/\/doi.org\/10.1016\/j.msec.2016.04.091","DOI":"10.1016\/j.msec.2016.04.091"},{"key":"3511_CR35","doi-asserted-by":"publisher","unstructured":"Sauter M, Sauter RJ, Nording H, Olbrich M, Emschermann F, Langer HF. Protocol to isolate and analyze mouse bone marrow derived dendritic cells (BMDC), (in eng). STAR Protoc. 2022;3(3):101664. https:\/\/doi.org\/10.1016\/j.xpro.2022.101664","DOI":"10.1016\/j.xpro.2022.101664"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03511-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-025-03511-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03511-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T21:13:15Z","timestamp":1749244395000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-025-03511-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,7]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3511"],"URL":"https:\/\/doi.org\/10.1186\/s12951-025-03511-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5971498\/v1","asserted-by":"object"}]},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,7]]},"assertion":[{"value":"6 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics and consent to participate declarations"}},{"value":"All authors agree to publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"425"}}